NCT04902651 is a NA clinical trial of HM242-Gel in Venous Leg Ulcer, sponsored by B. Braun Ltd. Centre of Excellence Infection Control.

Who is sponsoring NCT04902651?

NCT04902651 is sponsored by B. Braun Ltd. Centre of Excellence Infection Control.

What drugs are being tested in NCT04902651?

Interventions in NCT04902651: HM242-Gel, Intrasite Gel.

What condition does NCT04902651 study?

NCT04902651 studies Venous Leg Ulcer.

Is NCT04902651 still recruiting?

NCT04902651 is currently terminated. Last updated 19 July 2022.

Last reviewed 2022-07-19 · How we verify

NCT04902651

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HM242-Gel vs Comparator

Terminated NA Last updated 19 July 2022

What this trial tests

NA trial testing HM242-Gel in Venous Leg Ulcer in 73 participants. Terminated before completion.

Timeline

21 May 2021

Primary endpoint
5 January 2022

16 February 2022

Quick facts

Lead sponsor	B. Braun Ltd. Centre of Excellence Infection Control
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	73
Start date	21 May 2021
Primary completion	5 January 2022
Estimated completion	16 February 2022
Sites	3 locations across Slovakia, Czechia

Drugs / interventions tested

HM242-Gel
Intrasite Gel

Conditions studied

Venous Leg Ulcer — all drugs for Venous Leg Ulcer →

Sponsor

B. Braun Ltd. Centre of Excellence Infection Control — full company profile →

Who can join

18 and older, any sex, with Venous Leg Ulcer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to demonstrate that the HM242-Gel performs at least comparably to INTRASITE Gel with regard to wound healing.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Venous Leg Ulcer

Currently open trials in the same condition.

NCT07255937 — PMCF Study of Debridement Pad · NA · recruiting
NCT07046767 — CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations · NA · recruiting
NCT07211243 — Suprasorb®X+PHMB Pro vs Suprasorb®X+PHMB in Treatment of Infected Venous Leg Ulcers · NA · recruiting
NCT07061613 — Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Venous Leg Ulcers · NA · recruiting
NCT06544564 — Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population · NA · recruiting

Other B. Braun Ltd. Centre of Excellence Infection Control trials

Trials by the same sponsor.

NCT06920953 — Participant Satisfaction and Quality of Life With Catheter Washouts in Adults Living With Long-Term Catheters and Curren · not yet recruiting
NCT04192123 — Open-Label Test of the HM242 Medical Devices to Evaluate Safety and Local Tolerability · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04902651 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by B. Braun Ltd. Centre of Excellence Infection Control
Last refreshed: 19 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04902651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing